Recordati

REC

IT0003828271

Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (32.1%). Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).

Sector

Pharmaceuticals

Calendar

2024-06-24 - Stifel European Healthcare Summit

Related indices

STOXX EUROPE 600 (EUR) , FTSE MIB INDEX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

Recordati: An Italian mid-cap that has everything going for it

February 02, 2024 at 05:19 am

More Strategies

Ratings for Recordati

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

49.2 EUR

Average target price

52.64 EUR

Spread / Average Target

+6.99%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
RECORDATI	+0.76%	10.8B
ELI LILLY AND COMPANY	+51.63%	796B
NOVO NORDISK A/S	+41.51%	628B
JOHNSON & JOHNSON	-5.10%	358B
MERCK & CO., INC.	+19.90%	331B
ABBVIE INC.	+9.95%	301B
ASTRAZENECA PLC	+17.66%	244B
ROCHE HOLDING AG	+3.39%	228B
NOVARTIS AG	+10.75%	214B
AMGEN INC.	+6.99%	165B

Other Pharmaceuticals

Market Closed - Borsa Italiana Other stock markets 11:44:59 2024-06-21 EDT			5-day change	1st Jan Change
49.2 ^EUR	-0.08%		+2.29%	+0.76%

06-18	Recordati acquires treasury shares for more than EUR4 million	AN
06-18	Milan stock market continues tonic with banks, Leonardo and Recordati well, Moncler suffers	RE

Recordati acquires treasury shares for more than EUR4 million	06-18	AN
Milan stock market continues tonic with banks, Leonardo and Recordati well, Moncler suffers	06-18	RE
Recordati shares rise as investors reportedly circle CVC stake	06-18	RE
Mib rises to 33,200 area; purchases on Recordati	06-18	AN
Milan stock exchange, positive start with Europe driven by banks, Recordati rises	06-18	RE
Sector Update: Financial Stocks Rise Late Afternoon	06-17	MT
Sector Update: Financial	06-17	MT
KKR, TPG Said to be Interested in Recordati	06-17	MT
KKR, TPG Interested in Italian Drugmaker Recordati, Bloomberg Reports	06-17	MT
Stock markets in the green; BPER Bank leads the rises	06-12	AN
Recordati buys back more than 50,000 of its own ordinary shares	06-11	AN
Recordati continues buyback plan; nearly 64,000 shares purchased	06-04	AN
Recordati acquires treasury shares for more than EUR3 million	05-27	AN
Global markets live: Microsoft, Roche, BMW, Nintendo, Nordson...	05-21
Recordati purchased treasury shares for EUR3.8 million	05-20	AN
Futures bullish; Mib restarts at 34,300 level	05-10	AN
Mib up, Nexi and Prysmian good after accounts	05-09	AN
Recordati initiates buyback for maximum EUR85 million	05-09	AN
Transcript : Recordati Industria Chimica e Farmaceutica S.p.A., Q1 2024 Earnings Call, May 09, 2024	05-09
CVC Reportedly Taps Advisors to Study Options for Italy's Recordati	05-09	CI
China confirms its awakening	05-09
Recordati, revenues and Ebitda up double digits in quarter	05-09	AN
Recordati Industria Chimica e Farmaceutica S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-08	CI
MIb down; Leonardo bats a path after accounts	05-08	AN
Mib in green; UniCredit and MPS boost profit	05-07	AN